MoneyWorks4Me

Lasa Supergenerics informs about certificate

15 Jan 2026 Evaluate
Lasa Supergenerics has informed that it enclosed a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025 received from Bigshare Services, Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..